Drug Side Effects
Search
ADENOSQUAMOUS CELL CARCINOMA
ADENOSQUAMOUS CELL CARCINOMA
was reported 18 times
These drug classes are most commonly taken by patients reporting ADENOSQUAMOUS CELL CARCINOMA:
#
Drug
Count
0
Kinase Inhibitor [EPC]
6
1
Folate Analog Metabolic Inhibitor [EPC]
4
2
Microtubule Inhibitor [EPC]
3
3
Platinum-based Drug [EPC]
3
4
Topoisomerase Inhibitor [EPC]
3
5
Corticosteroid [EPC]
2
6
Thalidomide Analog [EPC]
2
7
Angiotensin Converting Enzyme Inhibitor [EPC]
1
8
Aromatase Inhibitor [EPC]
1
9
CD20-directed Cytolytic Antibody [EPC]
1
10
CD38-directed Cytolytic Antibody [EPC]
1
11
Dihydropyridine Calcium Channel Blocker [EPC]
1
12
Insulin Analog [EPC]
1
13
Integrin Receptor Antagonist [EPC]
1
14
Interleukin-23 Antagonist [EPC]
1
15
Osmotic Laxative [EPC]
1
16
Phosphodiesterase 4 Inhibitor [EPC]
1
17
Stimulant Laxative [EPC]
1
18
Vascular Endothelial Growth Factor Inhibitor [EPC]
1
19
Xanthine Oxidase Inhibitor [EPC]
1